After 622 Deaths, Philippines Government Announces A National Dengue Epidemic
The Philippines announced the national dengue epidemic after the death of 623 citizens due to dengue, which is a mosquito-borne disease, and many people are at risk. “From January, about 146,001 cases are recorded up to 20th July, which is 98% more than the last year,” said by Philippines Health Department. The symptoms of dengue are piercing headaches, joint and muscle pains, rashes on full-body, and high fever. According to the WHO (World Health Organization), millions of citizens are infected by dengue every year in the world, out of them 500,001 create severe symptoms demanding hospitalization, and out of them, about 12,500 people die.
In last month the Philippines announced national dengue alert, after recording more than 451 deaths. With about three hundred extra deaths in the previous month, the emergency has now heightened to a national epidemic. Health Ministry of Philippines said that the epidemic was announced in such a way that enable Philippines government agencies to well identify at infected areas. Out of 17 country regions, the epidemic has been declared in seven areas. These regions are Mimaropa, Western Visayas, Calabarzon, Bicol, Zamboanga Peninsula, Northern Mindanao, and Eastern Visayas. The regions like Ilocos and Central Visayas are at very high risk with more than thousands of cases.
At the press conference, Francisco Duque, the health secretary, said that “Per week 1500 cases were recorded.” Health Department of the Philippines allocates more than hundred of nurses and doctors to district hospitals in high-risk areas with emergency funding, said by the health department. Dengvaxia vaccine is only licensed and the world’s first dengue vaccine. Dengvaxia vaccine is made by Sanofi, which is a French pharmaceutical company. In Asia, the Philippines is the first country which approves Dengvaxia Vaccines use. This drug is circulated to about 800,000 students in the Philippines under a government immunization program. But there are some adverse effects of the Dengvaxia, so the government has no instant ideas to reintroduce the Dengvaxia vaccine to the common public, said by Mark Timbal.